AR

ARGX

XNAS

argenx SE

Mkt Cap $46.3B

TECHNICAL ANALYSIS

Mixed

RSI-14

51.1

Neutral

MACD

6.810

Bearish

SMA-50

$759.02

$759.02

SMA-200

$780.36

$780.36

BOLL %B

0.36

Within bands

ATR-14

$19.82

RVOL

0.00x

Low activity

MOMENTUM

+0.4%

10d -7.7% / 30d +14.5%

Analysis History

AI PREDICTION

No prediction yet

Tap Analyze to generate

ANALYST CONSENSUS

92% Buy

23 Buy2 Hold0 Sell

Low

$873

Mean

$1070

High

$1502

Latest Headlines

Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease

Benzinga5/11/2026

FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis

GlobeNewswire Inc.5/8/2026

argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

GlobeNewswire Inc.4/30/2026

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

GlobeNewswire Inc.4/18/2026